Adrenal incidentaloma
incidentaloma · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
An adrenal mass found unexpectedly on imaging done for another reason. Evaluation focuses on excluding hormone excess and malignancy, since most are benign non-functioning adenomas.
Red flags
- Size >4 cm or rapid growth
- Unenhanced attenuation >10 HU with poor washout (malignancy)
- Biochemical phaeochromocytoma
- Virilisation/feminisation (adrenocortical carcinoma)
- Bilateral masses with adrenal insufficiency
Assessment
Differential diagnosis
- Non-functioning adenoma
- Cortisol-secreting adenoma (including mild autonomous secretion)
- Phaeochromocytoma
- Aldosterone-producing adenoma
- Adrenocortical carcinoma
- Metastasis
- Myelolipoma
Investigations
- Dedicated adrenal CT with unenhanced Hounsfield units and washout
- 1 mg overnight dexamethasone suppression test
- Plasma/24h urinary metanephrines
- Aldosterone-to-renin ratio if hypertensive/hypokalaemic
- Androgens/steroid precursors if virilisation or carcinoma suspected
Management
- Characterise the mass on imaging: size, lipid content (HU) and washout
- Screen all patients for phaeochromocytoma and autonomous cortisol secretion
- Screen hypertensive/hypokalaemic patients for primary aldosteronism
- Interpret dexamethasone test: cortisol >50 nmol/L indicates possible autonomous secretion
- Refer indeterminate (>10 HU, poor washout) or large (>4 cm) lesions for surgical assessment
- Resect confirmed functioning tumours and suspected adrenocortical carcinoma
- For mild autonomous cortisol secretion, manage comorbidities and consider surgery case by case
- Follow benign non-functioning lesions with limited interval imaging/biochemistry
- Give perioperative steroid cover after removal of cortisol-secreting tumours
Drugs & doses
Alpha-blockade (e.g. phenoxybenzamine/doxazosin) before any phaeochromocytoma surgery
Hydrocortisone perioperative cover after resection of cortisol-secreting adenoma
Mineralocorticoid receptor antagonist if aldosterone excess confirmed and inoperable
Disposition
Investigate via endocrinology; refer functioning, large or indeterminate lesions to adrenal surgery and arrange structured follow-up for benign masses.
Complications & pitfalls
- Undetected phaeochromocytoma crisis during surgery
- Missed cortisol/aldosterone excess with cardiometabolic harm
- Adrenocortical carcinoma progression if resection delayed
- Adrenal insufficiency after unilateral adrenalectomy for autonomous cortisol
Exam pearls
- Every incidentaloma needs metanephrines and a dexamethasone suppression test, even if asymptomatic
- A homogeneous lesion <10 HU is almost always a benign adenoma
- Mild autonomous cortisol secretion is common and linked to hypertension, diabetes and fractures
- Never biopsy an adrenal mass until phaeochromocytoma is excluded
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.